NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025
A. Dimitrios Colevas(Cancer Institute (WIA)), Susan Darlow(National Comprehensive Cancer Network), David G. Pfister(Memorial Sloan Kettering Cancer Center), David J. Sher(DePaul University), Sharon A. Spencer(University of Alabama at Birmingham), Ellie Maghami(City Of Hope National Medical Center), Debra S. Leizman(Cleveland Clinic), James W. Rocco(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Christine M. Glastonbury(University of California, San Francisco), Maie A. St. John(University of Colorado Cancer Center), Francis P. Worden(Georgetown University), Jatin P. Shah(Memorial Sloan Kettering Cancer Center), Katharine A. Price(WinnMed), Ying J. Hitchcock(University of Utah), Justine Y. Bruce(University of Wisconsin Carbone Cancer Center), Loren K. Mell(University of California San Diego), Anthony J. Cmelak(Breast Cancer Research Foundation), David M. Brizel(Duke University), Andrew C. Birkeland(University of California, Davis), Paul M. Busse(Massachusetts General Hospital), Jimmy J. Caudell(Moffitt Cancer Center), Sarah Montgomery(National Comprehensive Cancer Network), Carole Fakhry(Johns Hopkins University), Michael Kase(University of Alabama at Birmingham), Greg Andrew Durm(Indiana University Health), Wesley L. Hicks, Maura L. Gillison(The University of Texas MD Anderson Cancer Center), J.L. Geiger(Cleveland Clinic), Robert I. Haddad(Georgetown University), Thomas J. Galloway(Fox Chase Cancer Center), Sue S. Yom(University of California, San Francisco), He Wang(The University of Texas MD Anderson Cancer Center), Cristina P. Rodriguez(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Antonio Jimeno(The Medical Center of Aurora), Douglas Adkins(Washington University in St. Louis), Gregory S. Weinstein(University of Pennsylvania), Weining Zhen(Susan Thompson Buffett Foundation), Aditya Juloori(University of Chicago Medicine Comprehensive Cancer Center), Bharat B. Mittal(Northwestern University), Harlan A. Pinto(Cancer Institute (WIA)), David A. Schwartz(St. Jude Children's Research Hospital)
Cited by 140
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
|Journal of Clinical Oncology|2011|3.6k
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2004|3.2k